Compare VPG & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VPG | CTKB |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.5M | 595.2M |
| IPO Year | 2010 | 2021 |
| Metric | VPG | CTKB |
|---|---|---|
| Price | $98.71 | $3.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $53.50 | $5.63 |
| AVG Volume (30 Days) | 385.3K | ★ 792.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $307,202,000.00 | $193,015,000.00 |
| Revenue This Year | $7.21 | $5.42 |
| Revenue Next Year | $6.92 | $7.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.22 | ★ 17.67 |
| 52 Week Low | $24.89 | $2.37 |
| 52 Week High | $105.17 | $6.18 |
| Indicator | VPG | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 86.18 | 27.99 |
| Support Level | $28.93 | $3.28 |
| Resistance Level | N/A | $4.26 |
| Average True Range (ATR) | 5.35 | 0.28 |
| MACD | 4.06 | -0.15 |
| Stochastic Oscillator | 86.47 | 7.74 |
Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.